For those living with treatment-resistant depression, the journey to relief can be long and exhausting. When multiple antidepressants and therapies fail to bring lasting results, innovative brain-based treatments like TMS and Spravato are offering real hope.
Both are FDA-approved, evidence-based options for people who haven’t responded to traditional medications. Yet, they work in very different ways—and in some cases, combining TMS and Spravato can create even more powerful outcomes.
Let’s break down how TMS and Spravato differ, how they can complement one another, and what patients should know before starting either—or both—treatments.
How do TMS and Spravato differ in mechanism, treatment process, and suitability?
While both TMS and Spravato target the brain to improve mood, they work through distinct mechanisms.
- TMS (Transcranial Magnetic Stimulation) uses focused magnetic pulses to activate underactive brain regions, particularly in the prefrontal cortex. It helps “retrain” mood circuits and restore balance over time.
- Spravato (esketamine nasal spray) acts chemically, influencing glutamate—the brain’s most abundant neurotransmitter—to quickly promote new neural connections and lift mood.
TMS and Spravato also differ in treatment delivery:
- TMS therapy involves sitting comfortably while a magnetic coil delivers pulses to the scalp, five days a week for four to six weeks.
- Spravato is administered via nasal spray in a certified clinic, typically twice a week for the first month, then once weekly or biweekly.
In short, TMS and Spravato take different paths to the same destination: improving brain function and alleviating depression. Some patients respond better to one, while others benefit most from combining both.
Can a patient receive both TMS and Spravato treatments, and what are the benefits or considerations of combining them?
Yes—many clinics now offer TMS and Spravato in combination for patients with severe or long-standing depression. Because their mechanisms are distinct yet complementary, they can work together to produce more comprehensive results.
Potential benefits of combining TMS and Spravato include:
- Faster symptom relief (Spravato’s rapid effects) paired with longer-lasting stability (TMS’s cumulative benefits).
- Dual action on different brain systems—electrical (TMS) and chemical (Spravato)—to enhance overall brain connectivity.
- Better outcomes for patients who’ve not responded to a single treatment modality.
However, combination treatment requires careful medical oversight. Clinicians assess how each therapy affects the patient’s mood, cognition, and energy before integrating the two. Timing and scheduling are also important—sessions may be staggered to avoid overstimulation or side effect overlap.
When administered correctly, TMS and Spravato together can offer a powerful, synergistic approach to even the most resistant forms of depression.
When should TMS be considered versus Spravato (or vice-versa) in treatment-resistant depression?
Choosing between TMS and Spravato depends on each individual’s medical history, comfort level, and response to previous treatments.
You might start with TMS if you:
- Prefer a non-medication option.
- Are sensitive to drug side effects or interactions.
- Want a gradual, brain-training approach that builds over time.
You might begin with Spravato if you:
- Need rapid symptom relief, especially if suicidal thoughts are present.
- Have tried several antidepressants without response.
- Are comfortable with a medication-based, in-clinic procedure.
Sometimes, patients start with Spravato to achieve faster relief, then continue with TMS to reinforce long-term brain stability. In others, TMS is used first to strengthen brain networks, and Spravato is added later for additional support.
In treatment-resistant depression, the goal is personalization—identifying whether TMS and Spravato, separately or together, offer the best path to recovery.
What are the insurance, cost, and logistical differences between TMS therapy and Spravato treatment?
Both TMS and Spravato are FDA-approved for treatment-resistant depression, and most major insurance providers cover them when medical necessity is documented. However, coverage details and out-of-pocket costs can differ.
TMS therapy:
- Typically covered after documentation of failed antidepressant trials.
- Treatment courses last 7 weeks, with five sessions per week.
- Each session lasts about 30 minutes, with no recovery time needed.
- Costs can range from $6,000–$12,000 per full course without insurance.
Spravato treatment:
- Also covered for treatment-resistant depression under most plans.
- Requires in-clinic administration and post-dose monitoring (around two hours per visit).
- Dosing is usually twice a week initially, then tapers to once weekly or biweekly.
- Out-of-pocket costs vary depending on insurance, copays, and deductibles, but manufacturer assistance programs are available.
Clinically, TMS and Spravato complement each other well—but logistically, combining both requires planning for time, cost, and transportation (since Spravato can cause temporary sedation).
A Personalized Approach to Healing
Depression doesn’t look the same for everyone—and neither should treatment. By understanding how TMS and Spravato differ and how they can work together, patients and clinicians can create customized plans that deliver both short-term relief and long-term recovery.
At our practice, we specialize in integrative psychiatry and personalized treatment for depression, offering both TMS and Spravato under one roof. Our team will help determine the right approach for you—whether it’s TMS, Spravato, or a carefully coordinated combination of both.
If you’re ready to explore how TMS and Spravato can help you move beyond treatment-resistant depression, reach out today. Hope and healing may be closer than you think.